FDA Fast Track for tazbentetol follows positive Phase 2a signals — next stop: phase 3
The FDA has granted Fast Track designation to tazbentetol, an oral drug from Spinogenix that uses a synaptic-regenerative mechanism to…
The FDA has granted Fast Track designation to tazbentetol, an oral drug from Spinogenix that uses a synaptic-regenerative mechanism to…